NCT04433234Active, not recruitingPhase 2
Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
A Phase II, Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Source: ClinicalTrials.gov · Last updated 6 Oct 2026
Brief summary (registry, in English)
This is a multicenter, open-label, long-term, extension, phase 2 study to evaluate the safety and efficacy of long-term treatment with DS-5141b in patients with DMD who have completed DS5141-A-J101.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- First submitted
- 12 Jun 2020
- Start date
- 30 Jun 2020
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT04433234
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 8
- From 30 Jun 2020 to the primary completion date, 31 Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Significant safety issues in a study of DS5141-A-J101
- Patient who does not consent to use appropriate contraception
- Patient not appropriate to participant in the study as determined by the Investigator
Who the study is looking for
- Has competed a study of DS5141-A-J101
Age in the registry: 5 years to - · Sex: Male · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kobe University Hospital Coordinator of this site? Confirm its status | Hyōgo | Japan | Unknown status |
| National Center of Neurology and Psychiatry Coordinator of this site? Confirm its status | Tokyo | Japan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.